CARDLYTICS, INC. (CDLX) Net margin 2016–2025
CARDLYTICS, INC. (CDLX) net profit margin by fiscal year — reported net income divided by reported revenue.
-48.7%FY2025 · since FY2016: -67.1% → -48.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -48.7% | +25.3 pp |
| FY2024 | -74.1% | -26.9 pp |
| FY2023 | -47.2% | +120.7 pp |
| FY2022 | -167.9% | -118.2 pp |
| FY2021 | -49.7% | -20.0 pp |
| FY2020 | -29.7% | -21.5 pp |
| FY2019 | -8.1% | +27.1 pp |
| FY2018 | -35.2% | -20.1 pp |
| FY2017 | -15.1% | +52.0 pp |
| FY2016 | -67.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CDLX financial trends
CDLX RevenueCDLX Net incomeCDLX Gross profitCDLX Gross marginCDLX Operating incomeCDLX Operating marginCDLX Operating cash flowCDLX Free cash flowCDLX Capital expendituresCDLX Return on equityCDLX Stock buybacksCDLX Dividends paidCDLX Total assetsCDLX Total liabilitiesCDLX Shareholders’ equityCDLX overview →